Background: Differentiating etiologies of acute kidney injury (AKI) is critical in determining the course of care in clinical practice. For example, acute interstitial nephritis (AIN) requires withdrawal of the offending drug and immunosuppressive therapy, while acute tubular injury (ATI) does not have any disease-specific therapies. Failure to distinguish AIN from ATI in a timely manner can lead to kidney fibrosis and chronic kidney disease. In this review, we discuss current tests and novel biomarkers to distinguish ATI from AIN. Summary: In a prospective cohort study of 32 participants with AIN and 41 with ATI, clinical features and current, laboratory tests did not provide sufficient distinction between the 2 subpopulations of AKI. The findings in our cohort are consistent with our review of the literature. Given the limitations of clinical features and laboratory assessments, clinical practice relies on kidney biopsy for histological diagnosis, which is not always feasible, and is associated with bleeding complications in high-risk populations. In addition, histological diagnosis is prone to sampling errors and inter-rater variability. In the interest of identifying a novel biomarker, we compared urine and plasma levels of cytokines in the Th1, Th2, and Th9 pathways, which have been implicated in the pathogenesis of AIN. Urine TNF-α and interleukin-9 were higher in AIN participants than in ATI controls and helped discriminate AIN from ATI (area under curve 0.83 [0.73–0.92]). Key Messages: Differentiation between AIN and ATI in patients with AKI using currently available tests is challenging. Urine TNF-α and interleukin-9 may help clinicians separate AIN from ATI.

Keywords:
Acute renal injury, Fibrosis, Kidney, Nephrology
1.
Raghavan R, Eknoyan G. Acute interstitial nephritis – a reappraisal and update.
Clin Nephrol
. 2014 Sep;82(3):149–62.
2.
Moledina DG, Wilson FP, Pober JS, Perazella MA, Singh N, Luciano RL, et al. Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.
JCI Insight
. 2019 May;4(10):4.
3.
Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly.
Kidney Int
. 2015 Feb;87(2):458–64.
4.
Bhaumik SK, Kher V, Arora P, Rai PK, Singhal M, Gupta A, et al. Evaluation of clinical and histological prognostic markers in drug-induced acute interstitial nephritis.
Ren Fail
. 1996 Jan;18(1):97–104.
5.
Chu R, Li C, Wang S, Zou W, Liu G, Yang L. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease.
Clin J Am Soc Nephrol
. 2014 Jul;9(7):1175–82.
6.
Fogazzi GB, Ferrari B, Garigali G, Simonini P, Consonni D. Urinary sediment findings in acute interstitial nephritis.
Am J Kidney Dis
. 2012 Aug;60(2):330–2.
7.
Wu Y, Yang L, Su T, Wang C, Liu G, Li XM. Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis.
Clin J Am Soc Nephrol
. 2010 Nov;5(11):1954–9.
8.
Graham F, Lord M, Froment D, Cardinal H, Bollée G. The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis.
Clin Kidney J
. 2016 Feb;9(1):76–81.
9.
Liapis H, Gaut JP, Klein C, Bagnasco S, Kraus E, Farris AB 3rd, et al.; Banff Working Group. Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies.
Am J Transplant
. 2017 Jan;17(1):140–50.
10.
Moledina DG, Luciano RL, Kukova L, et al. Kidney Biopsy-Related Complications in Hospitalized Patients with Acute Kidney Disease.
Clin J Am Soc Nephrol
. 2018 Nov 7;13(11):1633–40.
11.
Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
Am J Kidney Dis
. 2014 Oct;64(4):558–66.
12.
Spanou Z, Keller M, Britschgi M, Yawalkar N, Fehr T, Neuweiler J, et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis.
J Am Soc Nephrol
. 2006 Oct;17(10):2919–27.
13.
Zand L, Monaghan M, Griffin BR, Wagner SJ, Criaci IM, Kamal A, et al. The role of type I hypersensitivity reaction and IgE-mediated mast cell activation in acute interstitial nephritis.
Clin Nephrol
. 2015 Sep;84(3):138–44.
14.
D’Agati VD, Theise ND, Pirani CL, Knowles DM, Appel GB. Interstitial nephritis related to nonsteroidal anti-inflammatory agents and beta-lactam antibiotics: a comparative study of the interstitial infiltrates using monoclonal antibodies.
Mod Pathol
. 1989 Jul;2(4):390–6.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.